Share this post on:

Name :
HIST1H1T antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
HIST1H1T Rabbit Polyclonal antibody. Positive WB detected in mouse lung tissue, mouse kidney tissue, mouse testis tissue. Observed molecular weight by Western-blot: 30 kDa

Tested applications :

Species reactivity :
Human, Mouse; other species not tested.

Alternative names :
dJ221C16.2 antibody; H1FT antibody; H1t antibody; HIST1H1T antibody; histone cluster 1 antibody; H1t antibody; Histone H1t antibody; Testicular H1 histone antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of HIST1H1T recombinant protein (Accession Number: NM_005323). Purification method: Antigen affinity purified.

Clonality :

Formulation :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: WB: 1:200-1:1000

Background :
HIST1H1T represents histone cluster 1, H1t

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites:
Popular product recommendations:
ULK1 Antibody
Chk1 Antibody
Calumenin Antibody (YA813): Calumenin Antibody (YA813) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa, targeting to Calumenin (4C6). It can be used for WB assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Gardos- Channel